Questions@starscientific.com sent
NukeJohn, I took the liberty of sending in your question to the company
"In the past, Dr. Mullan has discussed a "cocktail" to treat Alzheimer's Disease and he has indicated researchers are getting very close to a solution. I recall that he has indicated that the cocktail consisted of somethijng to reduce inflammation, something to reduce beta amyloid plaque, and something else (which I can't recall).
Roskamp just signed a partenership with Anavex for Alzheimer's research. Are the Anavex drug and Anatabine going to be key components of the cocktail? "
Anybody else has questions, Please send them in. We've got maybe an hour of time that Dr. Mullen can give us, after the hour of "no forward looking statements, promises, and hopes" back covering. Let's make it interesting!
Also sent in your second question:
"Anatabine has been shown to reduce the transcription of NF-kB which leads to inflammation in the body, but I think many people don't take enough to cokmpletely control the inflammation and see the benefits. The proper dosage needs to be determined on each individual, and it needs to be regulated so the user gets enough to reach therapuetic levels. It took me over a year of trail and error to get the right dosage for me. I saw benefits at lower dosages, but maximum benefits at my current dose.
It would be great if there was a way to measure inflammation in the body (ie CRP) with a quick test, just like a diabetic measures his insulin levels. My question would be this....
Is there any quick way to for people to measure the level of inflammation in the body with an easy self-test method like diabetics use for blood sugar? "
